Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations

Samankaltaisia teoksia

• Survey of International Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products
  Tekijä: Braddy, April C., et al.
  Julkaistu: (2014)
• Common Reasons for “For-Cause” Inspections in Bioequivalence Studies Submitted to the Food and Drug Administration
  Tekijä: Li, Bing V., et al.
  Julkaistu: (2012)
• A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH
  Tekijä: Zhu, Hao, et al.
  Julkaistu: (2019)
• Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA
  Tekijä: Liu, Qing, et al.
  Julkaistu: (2011)
• Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations
  Tekijä: Endrenyi, Laszlo, et al.
  Julkaistu: (2012)